NCT00602004View on ClinicalTrials.gov

Attenuation of Cardiac Effects of Arteriovenous Fistula Creation With Losartan

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

August 31, 2014

Study Completion Date

December 31, 2014

Conditions
Renal FailureLeft Ventricular Hypertrophy
Interventions
DRUG

losartan

losartan 50 mg a day

Trial Locations (1)

3150

Royal Melbourne Hospital, Parkville

Sponsors

Lead Sponsor

Melbourne Health
All Listed Sponsors
lead

Melbourne Health

OTHER